177 related articles for article (PubMed ID: 28505674)
21. Uveal melanoma: A pathologist's perspective and review of translational developments.
Schoenfield L
Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
[TBL] [Abstract][Full Text] [Related]
22. A Novel Model of Metastatic Conjunctival Melanoma in Immune-Competent Mice.
Schlereth SL; Iden S; Mescher M; Ksander BR; Bosch JJ; Cursiefen C; Heindl LM
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5965-73. PubMed ID: 26377082
[TBL] [Abstract][Full Text] [Related]
23. Immunological studies in patients with malignant melanoma of the uvea.
Brownstein S; Sheikh KM; Lewis MG
Can J Ophthalmol; 1977 Jan; 12(1):16-23. PubMed ID: 849536
[TBL] [Abstract][Full Text] [Related]
24. [Adjuvant therapy and interdisciplinary follow-up care of conjunctival melanoma].
Heindl LM; Koch KR; Schlaak M; Mauch C; Cursiefen C
Ophthalmologe; 2015 Nov; 112(11):907-11. PubMed ID: 26502167
[TBL] [Abstract][Full Text] [Related]
25. Clinical Management of Uveal and Conjunctival Melanoma.
Blum ES; Yang J; Komatsubara KM; Carvajal RD
Oncology (Williston Park); 2016 Jan; 30(1):29-32, 34-43, 48. PubMed ID: 26791842
[TBL] [Abstract][Full Text] [Related]
26. Tissue distribution and biochemical properties of an ocular melanoma-associated antigen.
Donoso LA; Folberg R; Edelberg K; Arbizo V; Atkinson B; Herlyn M
J Histochem Cytochem; 1985 Dec; 33(12):1190-6. PubMed ID: 3905953
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy of melanoma: present options and future promises.
Rotte A; Bhandaru M; Zhou Y; McElwee KJ
Cancer Metastasis Rev; 2015 Mar; 34(1):115-28. PubMed ID: 25589384
[TBL] [Abstract][Full Text] [Related]
28. Melanoma immunotherapy: historical precedents, recent successes and future prospects.
Raaijmakers MI; Rozati S; Goldinger SM; Widmer DS; Dummer R; Levesque MP
Immunotherapy; 2013 Feb; 5(2):169-82. PubMed ID: 23413908
[TBL] [Abstract][Full Text] [Related]
29. Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases.
Bock F; Maruyama K; Regenfuss B; Hos D; Steven P; Heindl LM; Cursiefen C
Prog Retin Eye Res; 2013 May; 34():89-124. PubMed ID: 23348581
[TBL] [Abstract][Full Text] [Related]
30. Circulating melanoma-associated antigens in ocular melanoma.
Whitmore WG; Witkin SS; Ellsworth RM
Ann Ophthalmol; 1988 Jun; 20(6):212-7. PubMed ID: 3408088
[TBL] [Abstract][Full Text] [Related]
31. Update on Metastatic Uveal Melanoma: Progress and Challenges.
Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
[TBL] [Abstract][Full Text] [Related]
33. Restoration of tumor equilibrium after immunotherapy for advanced melanoma: three illustrative cases.
Wilgenhof S; Pierret L; Corthals J; Van Nuffel AM; Heirman C; Roelandt T; De Coninck A; Verfaillie G; Vandenbroucke F; Van Riet I; Bonehill A; Thielemans K; Neyns B
Melanoma Res; 2011 Apr; 21(2):152-9. PubMed ID: 21317818
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy for the management of advanced melanoma: the next steps.
Zikich D; Schachter J; Besser MJ
Am J Clin Dermatol; 2013 Aug; 14(4):261-72. PubMed ID: 23516145
[TBL] [Abstract][Full Text] [Related]
35. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa.
Ho VH; Ross MI; Prieto VG; Khaleeq A; Kim S; Esmaeli B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):820-6. PubMed ID: 17709624
[TBL] [Abstract][Full Text] [Related]
36. Melanoma and immunotherapy.
Eggermont AM; Schadendorf D
Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
[TBL] [Abstract][Full Text] [Related]
37. Isolated hepatic perfusion for ocular melanoma metastasis: registry data suggests a survival benefit.
Olofsson R; Cahlin C; All-Ericsson C; Hashimi F; Mattsson J; Rizell M; Lindnér P
Ann Surg Oncol; 2014 Feb; 21(2):466-72. PubMed ID: 24141377
[TBL] [Abstract][Full Text] [Related]
38. The role of systemic therapies in the management of melanoma brain metastases.
Lyle M; Long GV
Curr Opin Oncol; 2014 Mar; 26(2):222-9. PubMed ID: 24434634
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapy of melanoma: efficacy and mode of action.
Wieder T; Brenner E; Braumüller H; Röcken M
J Dtsch Dermatol Ges; 2016 Jan; 14(1):28-37. PubMed ID: 26713633
[TBL] [Abstract][Full Text] [Related]
40. Next generation of immunotherapy for melanoma.
Kirkwood JM; Tarhini AA; Panelli MC; Moschos SJ; Zarour HM; Butterfield LH; Gogas HJ
J Clin Oncol; 2008 Jul; 26(20):3445-55. PubMed ID: 18612161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
